Chemical Structure : EZH2 inhibitor C36
货号: PC-27108Not For Human Use, Lab Use Only.
EZH2 inhibitor C36 is a potent, selective and allosteric EZH2-PRC2 inhibitor with IC50 of 2.27 nM in AlphaLisa assays, inhibits both the basal and activated forms of the PRC2 complex containing EZH2, but not EZH1, in a SAM-noncompetitive manner.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
EZH2 inhibitor C36 is a potent, selective and allosteric EZH2-PRC2 inhibitor with IC50 of 2.27 nM in AlphaLisa assays, inhibits both the basal and activated forms of the PRC2 complex containing EZH2, but not EZH1, in a SAM-noncompetitive manner.
C36 inhibits the methyltransferase activity of PRC2 and PRC2-JARID2 with IC50 values of 121 and 66 nM, respectively.
C36 binds to a pocket at the interface of SET-Activation-Loop (SAL), stimulation-responsive motif (SRM), and I-SET domain of EZH2, and WD40 domain of EED.
C36 binding induces conformational changes and disrupts allosteric communication between EZH2 and ligand-bound EED.
EZH2 inhibitor C36 greatly reduced H3K27me3 in DLBCL cell lines harboring EZH2 wild-type (Toledo, OCI-ly19, SU-DHL-1) or GOF mutants (WSU-DLCL2, SU-DHL-4, Karpas422 Pfeiffer).
C36 efficiently inhibits H3K27 trimethylation and PRC2 target gene expression in tumor cells and xenograft tumors with low hematotoxicity.
| 分子量 | 481.99 | |
| 分子式 | C24H28ClN7O2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Cao T, et al. Adv Sci (Weinh). 2026 Jun 18:e76025.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright